Hailey Fe 1/20 Kit
Product Images NDC 68462-419

This appears to be a description of a medication called Hailey® Fe 1/20 that comes in a blister pack containing 21 white to off-white tablets and 7 brown to dark brown tablets, each intended for a specific purpose. The medication contains norethindrone acetate, ethinyl estradiol, and ferrous fumarate. The usual dose is one tablet daily for 28 days as directed by a physician, and the package insert should be consulted for full prescribing information. The medication is not intended to protect against HIV or other sexually transmitted diseases, and should be kept out of reach of children. The package is not child-resistant. The manufacturer is Glenmark Pharmaceuticals Limited located in Goa, India. The carton size and dimensions of the medication are also provided.*

This is a table showing Circulatory Disease Mortality Rates per 100,000 woman years categorized by age, smoking status and oral contraceptive use. The table has separate columns for mortality rate of ever-users (non-smokers), controls (non-smokers), ever-users (smokers), and controls (smokers) with data points ranging from 0-250. The age categories listed are 15-24, 25-34, 35-44, and 45-.*

This text is a set of instructions for a birth control pill pack. It outlines how to start the pill pack depending on the first day of the menstrual cycle - either on a Sunday or any other day. The text also provides a day label strip and shows how to take the pills each week.*

This text seems to be a set of instructions for women who want to start taking birth control pills. If their period begins on a day other than Sunday, they need to place a label strip that starts with "START HERE FOR BOTH the first day of your period". However, if their period starts on Sunday, they can follow the instructions for Sunday starters. The text includes a table with week numbers and corresponding days when the pills need to be taken. The pills should be taken in a left to right direction each week.*

This appears to be a list of studies comparing the use of combined oral contraceptives (COC) to never using them, as well as current use versus never use. The studies include NICHD Women’s Care Study, French E3N cohort Study, Shanghai Women's Health Study, The Nurses’ Health Study II, Danish Sex Hormone Register Study, and Oxford Family Planning Study. The table includes some effect estimate statistics, but it is unclear what they represent without additional context.*